Private Wealth Management Group’s Corcept Therapeutics CORT Stock Holding History

Private Wealth Management Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Hold	176	–	–	﹤0.01%	458
2026 Q1	$7.09K	Hold	176	–	–	﹤0.01%	642
2025 Q4	$6.13K	Hold	176	–	–	﹤0.01%	695
2025 Q3	$14.6K	Hold	176	–	–	﹤0.01%	412
2025 Q2	$12.9K	Hold	176	–	–	﹤0.01%	417
2025 Q1	$20.1K	Hold	176	–	–	0.01%	297
2024 Q4	$8.87K	Hold	176	–	–	﹤0.01%	518
2024 Q3	$8.15K	Hold	176	–	–	﹤0.01%	523
2024 Q2	$5.72K	Buy	176 +130	+283%	+$3.56K	﹤0.01%	656
2024 Q1	$1.16K	Sell	46 -14	-23%	-$331	﹤0.01%	1205
2023 Q4	$1.95K	Buy	+60	New	+$1.65K	﹤0.01%	992

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Management Group's CORT Position: Q2 2026 in Review

Private Wealth Management Group held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 176 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Private Wealth Management Group first reported a position in CORT in Q4 2023 and has held it in 11 quarters since. The position peaked at $20.1K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Private Wealth Management Group held 176 shares of Corcept Therapeutics worth $15.3K as of Q2 2026.
Private Wealth Management Group left its Corcept Therapeutics share count unchanged in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #458 holding.
Private Wealth Management Group first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Corcept Therapeutics position peaked at $20.1K in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.